Skye Bioscience (SKYE) Total Debt (2013 - 2026)
Skye Bioscience's Total Debt came in at $210,803 for Q2 2026, down 15.8% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Total Debt (2013 - 2026) Analysis & Trends
At the end of FY2023, Skye Bioscience's Total Debt was $4.37 million, up 136.5% from FY2022.
- Total Debt has increased in each of the last three years, with a five-year compound annual growth rate of 26.3% (FY2018 to FY2023).
- Going back by year, Total Debt was $1.85 million in FY2022 (+21.2%), $1.52 million in FY2021 (+196.6%) and $514,062 in FY2020.
- The Q2 2026 figure represents the lowest quarterly Total Debt since Q2 2023.
- The fastest year-over-year change in Total Debt over five years came in Q3 2021 (growth of 532.9%), and the weakest in Q2 2023 (a decline of 95.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - | 210,803.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210,803.00 |
| Mar 31, 2026 | 250,338.00 |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 4.14 Mn |
| Jun 30, 2023 | 90,615.00 |
| Mar 31, 2023 | 158,576.00 |
| Dec 31, 2022 | 1.85 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 1.84 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 450,000.00 |
| Jun 30, 2021 | 450,000.00 |
| Mar 31, 2021 | 553,523.00 |
| Dec 31, 2020 | 514,062.00 |
| Sep 30, 2020 | 71,102.00 |
| Jun 30, 2020 | 51,653.00 |
| Dec 31, 2018 | 1.36 Mn |
API Access
Skye Bioscience Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();